Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C21H17N9O2S |
| Molecular Weight | 459.484 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1C=C(C=N1)C2=CN3C(C=C2)=NC=C3S(=O)(=O)N4N=CC5=NC=C(C=C45)C6=CN(C)N=C6
InChI
InChIKey=RYBLECYFLJXEJX-UHFFFAOYSA-N
InChI=1S/C21H17N9O2S/c1-27-11-16(7-24-27)14-3-4-20-23-10-21(29(20)13-14)33(31,32)30-19-5-15(6-22-18(19)9-26-30)17-8-25-28(2)12-17/h3-13H,1-2H3
| Molecular Formula | C21H17N9O2S |
| Molecular Weight | 459.484 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Cmax
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
868.7 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36925997/ |
300 mg single, oral dose: 300 mg route of administration: Oral experiment type: SINGLE co-administered: |
GLUMETINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FASTED |
|
1729.8 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36925997/ |
300 mg single, oral dose: 300 mg route of administration: Oral experiment type: SINGLE co-administered: |
GLUMETINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: HIGH-FAT |
|
1748.9 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36925997/ |
300 mg single, oral dose: 300 mg route of administration: Oral experiment type: SINGLE co-administered: |
GLUMETINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: LOW-FAT |
AUC
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
27727 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36925997/ |
300 mg single, oral dose: 300 mg route of administration: Oral experiment type: SINGLE co-administered: |
GLUMETINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FASTED |
|
65089.9 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36925997/ |
300 mg single, oral dose: 300 mg route of administration: Oral experiment type: SINGLE co-administered: |
GLUMETINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: HIGH-FAT |
|
60508 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36925997/ |
300 mg single, oral dose: 300 mg route of administration: Oral experiment type: SINGLE co-administered: |
GLUMETINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: LOW-FAT |
T1/2
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
26.1 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36925997/ |
300 mg single, oral dose: 300 mg route of administration: Oral experiment type: SINGLE co-administered: |
GLUMETINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FASTED |
|
24.7 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36925997/ |
300 mg single, oral dose: 300 mg route of administration: Oral experiment type: SINGLE co-administered: |
GLUMETINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: HIGH-FAT |
|
25.6 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36925997/ |
300 mg single, oral dose: 300 mg route of administration: Oral experiment type: SINGLE co-administered: |
GLUMETINIB plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: LOW-FAT |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 00:26:45 GMT 2025
by
admin
on
Wed Apr 02 00:26:45 GMT 2025
|
| Record UNII |
7JTT036WGX
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
858221
Created by
admin on Wed Apr 02 00:26:45 GMT 2025 , Edited by admin on Wed Apr 02 00:26:45 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1642581-63-2
Created by
admin on Wed Apr 02 00:26:45 GMT 2025 , Edited by admin on Wed Apr 02 00:26:45 GMT 2025
|
PRIMARY | |||
|
7JTT036WGX
Created by
admin on Wed Apr 02 00:26:45 GMT 2025 , Edited by admin on Wed Apr 02 00:26:45 GMT 2025
|
PRIMARY | |||
|
117797905
Created by
admin on Wed Apr 02 00:26:45 GMT 2025 , Edited by admin on Wed Apr 02 00:26:45 GMT 2025
|
PRIMARY | |||
|
12133
Created by
admin on Wed Apr 02 00:26:45 GMT 2025 , Edited by admin on Wed Apr 02 00:26:45 GMT 2025
|
PRIMARY | |||
|
C156700
Created by
admin on Wed Apr 02 00:26:45 GMT 2025 , Edited by admin on Wed Apr 02 00:26:45 GMT 2025
|
PRIMARY | |||
|
DB15630
Created by
admin on Wed Apr 02 00:26:45 GMT 2025 , Edited by admin on Wed Apr 02 00:26:45 GMT 2025
|
PRIMARY | |||
|
300000045593
Created by
admin on Wed Apr 02 00:26:45 GMT 2025 , Edited by admin on Wed Apr 02 00:26:45 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|